Published online before print March 3, 2003, doi: 10.1161/01.CIR.0000056522.82563.5F
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2003;107:1390.)
© 2003 American Heart Association, Inc.
Clinical Investigation and Reports |
Mutations in the Human Muscle LIM Protein Gene in Families With Hypertrophic Cardiomyopathy
From the Universitätsklinikum Charité/Kardiologie am Campus Buch und Virchow Klinikum (C.G., A.P., C.O., K.H., B.P., Y.M., R.D., K.J.O.), Humboldt-Universität zu Berlin, Berlin, Germany; Max-Delbrück-Centrum für Molekulare Medizin (C.G., K.H., P.N.), Berlin-Buch, Germany; Institut für Molekulare und klinische Herz-Kreislaufforschung-Bereich Molekulargenetik (P.B., T.S.), Universität Witten-Herdecke, Germany; MRC Human Genome Mapping Project Resource Centre (D.C.), Hinxton, Cambridge, UK; Abteilung Zellbiologie, Institut für Biochemie und Biologie, Universität Potsdam (K.G., P.F.M.v.d.V., D.O.F.), Potsdam, Germany; DRK-Blutspendedienst Berlin (A.V.), Berlin, Germany; Herzzentrum Lahr/Baden (E.v.H.), Baden, Germany; and Universitätsklinikum Charité, Institut für Medizinische Genetik, Humboldt-Universität (P.N.), Berlin, Germany.
Correspondence to Prof Osterziel, Universitätsklinikum Charité Campus Buch, Franz-Volhard-Klinik, Wiltbergstraße 50, Haus 129, 13125 Berlin, Germany. E-mail karljosef.osterziel{at}charite.de
Background— Muscle LIM protein (MLP) is an essential nuclear regulator of myogenic differentiation. Additionally, it may act as an integrator of protein assembly of the actin-based cytoskeleton. MLP-knockout mice develop a marked cardiac hypertrophy reaction and dilated cardiomyopathy (DCM). MLP is therefore a candidate gene for heritable forms of hypertrophic cardiomyopathy (HCM) and DCM in humans.
Methods and Results— We analyzed 1100 unrelated individuals (400 patients with DCM, 200 patients with HCM, and 500 controls) for mutations in the human CRP3 gene that encodes MLP. We found 3 different missense mutations in 3 unrelated patients with familial HCM but detected no mutation in the DCM group or the controls. All mutations predicted an amino acid exchange at highly conserved residues in the functionally important LIM1 domain, which is responsible for interaction with 
-actinin and with certain muscle-specific transcription factors. Protein-binding studies indicate that mutations in the CRP3 gene lead to a decreased binding activity of MLP to -actinin. All 3 index patients were characterized by typical asymmetrical septal hypertrophy. Family studies revealed cosegregation of clinically affected individuals with the respective mutations in MLP.
Conclusion— Here, we present evidence that mutations in the CRP3/MLP gene can cause HCM.
Key Words: cardiomyopathy • genes • hypertrophy
Related Article:
Circulation 2003 107: 1344-1346.
This article has been cited by other articles:
 |
|
 |
|
  A. M. Samarel PICOT: A Multidomain Scaffolding Inhibitor of Hypertrophic Signal Transduction Circ. Res., March 28, 2008; 102(6): 625 - 627. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Morimoto Sarcomeric proteins and inherited cardiomyopathies Cardiovasc Res, March 1, 2008; 77(4): 659 - 666. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Mery, O. Taghli-Lamallem, K. A. Clark, M. C. Beckerle, X. Wu, K. Ocorr, and R. Bodmer The Drosophila muscle LIM protein, Mlp84B, is essential for cardiac function J. Exp. Biol., January 1, 2008; 211(1): 15 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Kostek, Y.-W. Chen, D. J. Cuthbertson, R. Shi, M. J. Fedele, K. A. Esser, and M. J. Rennie Gene expression responses over 24 h to lengthening and shortening contractions in human muscle: major changes in CSRP3, MUSTN1, SIX1, and FBXO32 Physiol Genomics, September 11, 2007; 31(1): 42 - 52. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Clark, J. M. Bland, and M. C. Beckerle The Drosophila muscle LIM protein, Mlp84B, cooperates with D-titin to maintain muscle structural integrity J. Cell Sci., June 15, 2007; 120(12): 2066 - 2077. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Geier, A. Perrot, and C. Ozcelik Letter by Geier et al Regarding Article, "Hypertrophic Cardiomyopathy Is Predominantly a Disease of Left Ventricular Outflow Tract Obstruction" Circulation, June 12, 2007; 115(23): e622 - e622. [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ashrafian and H. Watkins Reviews of Translational Medicine and Genomics in Cardiovascular Disease: New Disease Taxonomy and Therapeutic Implications: Cardiomyopathies: Therapeutics Based on Molecular Phenotype J. Am. Coll. Cardiol., March 27, 2007; 49(12): 1251 - 1264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hoshijima, R. Knoll, M. Pashmforoush, and K. R. Chien Reversal of Calcium Cycling Defects in Advanced Heart Failure: Toward Molecular Therapy J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A15 - A23. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Jeong, H. Cha, E. Kim, M. Kang, D. K. Yang, J. M. Kim, P. O. Yoon, J. G. Oh, O. Y. Bernecker, S. Sakata, et al. PICOT Inhibits Cardiac Hypertrophy and Enhances Ventricular Function and Cardiomyocyte Contractility Circ. Res., August 4, 2006; 99(3): 307 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hoshijima Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures Am J Physiol Heart Circ Physiol, April 1, 2006; 290(4): H1313 - H1325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Ackerman, S. L. Van Driest, and M. Bos Are Longitudinal, Natural History Studies the Next Step in Genotype-Phenotype Translational Genomics in Hypertrophic Cardiomyopathy? J. Am. Coll. Cardiol., November 1, 2005; 46(9): 1744 - 1746. [Full Text] [PDF]
|
|
|
|
 |
|
 I. A. Barash, L. Mathew, M. Lahey, M. L. Greaser, and R. L. Lieber Muscle LIM protein plays both structural and functional roles in skeletal muscle Am J Physiol Cell Physiol, November 1, 2005; 289(5): C1312 - C1320. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Osterziel and A. Perrot Dilated cardiomyopathy: more genes means more phenotypes Eur. Heart J., April 2, 2005; 26(8): 751 - 754. [Full Text] [PDF]
|
|
|
|
|
|
B. J.C. van den Bosch, C. M.M. van den Burg, K. Schoonderwoerd, P. J. Lindsey, H. R. Scholte, R. F.M. de Coo, E. van Rooij, H. A. Rockman, P. A. Doevendans, and H. J.M. Smeets Regional absence of mitochondria causing energy depletion in the myocardium of muscle LIM protein knockout mice Cardiovasc Res, February 1, 2005; 65(2): 411 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. P. V. Manh, M. Mokrane, E. Georgenthum, J. Flavigny, L. Carrier, M. Semeriva, M. Piovant, and L. Roder Expression of cardiac myosin-binding protein-C (cMyBP-C) in Drosophila as a model for the study of human cardiomyopathies Hum. Mol. Genet., January 1, 2005; 14(1): 7 - 17. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hayashi, T. Arimura, M. Itoh-Satoh, K. Ueda, S. Hohda, N. Inagaki, M. Takahashi, H. Hori, M. Yasunami, H. Nishi, et al. Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy J. Am. Coll. Cardiol., December 7, 2004; 44(11): 2192 - 2201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sasse-Klaassen, S. Probst, B. Gerull, E. Oechslin, P. Nurnberg, A. Heuser, R. Jenni, H. C. Hennies, and L. Thierfelder Novel Gene Locus for Autosomal Dominant Left Ventricular Noncompaction Maps to Chromosome 11p15 Circulation, June 8, 2004; 109(22): 2720 - 2723. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Mogensen, A Perrot, P S Andersen, O Havndrup, I C Klausen, M Christiansen, P Bross, H Egeblad, H Bundgaard, K J Osterziel, et al. Clinical and genetic characteristics of {alpha} cardiac actin gene mutations in hypertrophic cardiomyopathy J. Med. Genet., January 1, 2004; 41(1): e10 - 10. [Full Text] [PDF]
|
|
|
|
|
|
H. Watkins Genetic Clues to Disease Pathways in Hypertrophic and Dilated Cardiomyopathies Circulation, March 18, 2003; 107(10): 1344 - 1346. [Full Text] [PDF]
|
|